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Abstract
Much is anticipated from the development and deployment of nanomaterials in biological 
organisms, but concerns remain regarding their biocompatibility and target specificity. Here we 
report our study of the transport, biocompatibility and toxicity of purified and stable silver 
nanoparticles (Ag NPs, 13.1 ± 2.5 nm in diameter) upon the specific developmental stages of 
zebrafish embryos using single NP plasmonic spectroscopy. We find that single Ag NPs passively 
diffuse into five different developmental stages of embryos (cleavage, early-gastrula, early-
segmentation, late-segmentation, and hatching stages), showing stage-independent diffusion 
modes and diffusion coefficients. Notably, the Ag NPs induce distinctive stage and dose-
dependent phenotypes and nanotoxicity, upon their acute exposure to the Ag NPs (0–0.7 nM) for 
only 2 h. The late-segmentation embryos are most sensitive to the NPs with the lowest critical 
concentration (CNP,c ≪ 0.02 nM) and highest percentages of cardiac abnormalities, followed by 
early-segmentation embryos (CNP,c < 0.02 nM), suggesting that disruption of cell differentiation 
by the NPs causes the most toxic effects on embryonic development. The cleavage-stage embryos 
treated with the NPs develop to a wide variety of phenotypes (abnormal finfold, tail/spinal cord 
flexure, cardiac malformation, yolk sac edema, and acephaly). These organ structures are not yet 
developed in cleavage-stage embryos, suggesting that the earliest determinative events to create 
these structures are ongoing, and disrupted by NPs, which leads to the downstream effects. In 
contrast, the hatching embryos are most resistant to the Ag NPs, and majority of embryos (94%) 
develop normally, and none of them develops abnormality. Interestingly, early-gastrula embryos 
are less sensitive to the NPs than cleavage and segmentation stage embryos, and do not develop 
abnormally. These important findings suggest that the Ag NPs are not simple poisons, and they 
can target specific pathways in development, and potentially enable target specific study and 
therapy for early embryonic development.
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Nanomaterials have similar sizes to biological structures and exceptional surface properties. 
These distinctive properties enable them to serve as unique probes to study developmental 
processes during embryogenesis with specific potential applications.1–3 If nanomaterials can 
induce developmental stage- and dose-dependent abnormalities, these nanomaterials can 
then be used as probes to study early embryonic development, as screening tools in 
developmental biology to control and regulate key developmental processes, or as target-
specific regulators (therapeutic agents) for biomedical applications. In contrast to in vitro 
cell culture assays, whole animal studies enable one to study complex developmental 
processes that operate over time to form adult organisms.4–7
Noble metal nanoparticles (e.g., Ag NPs) possess distinctive optical properties with high 
Rayleigh scattering and superior photostability.2–3, 8–12 Their localized surface plasmon 
resonance (LSPR) spectra highly depend upon their physicochemical properties and 
surrounding environments,9–17 which enable us to use LSPR spectra of single Ag NPs to 
characterize their physicochemical properties (e.g., size, shape) in situ in real 
time.2–3, 16, 18–23 Unlike fluorescence molecules or quantum dots, single Ag NPs resist 
photobleaching and photoblinking.2–3, 8–9, 13, 21 These distinctive optical properties enable 
them to serve as photostable imaging probes for real-time study of nanoenvironments of 
living organisms and dynamic events of interest for any desired period of time.8, 13, 18, 21–23 
We have demonstrated that Ag NP-based single-molecule nanoparticle optical biosensors 
(SMNOBS) can serve as photostable optical sensors and imaging probes to image single live 
cells and embryos in real time at nm spatial and millisecond (ms) temporal 
resolutions.2–3, 8, 13, 18, 21–24
Zebrafish have been widely used as a vertebrate model organism for study of embryological 
development because of their small size, short breeding cycle, and wealth information for 
molecular genetic manipulation.6, 25–31 Its transparency throughout development enables 
observation of internal organ development outside the chorion without disturbing the living 
embryo. Their embryonic development is so rapid that the early-development stages are 
nearly completed in the first 24 h after fertilization, and the normally developed embryo will 
hatch and swim by 72 h. Furthermore, the majority of the developmental mutations 
identified in zebrafish have close counterparts in other vertebrates,26, 32–34 suggesting that 
this organism can effectively be used as a model for understanding the developmental 
processes of higher organisms, including humans. Therefore, zebrafish embryos offer a 
unique opportunity to study developmental processes upon exposure to nanomaterials and to 
investigate the stage-dependent effects of nanomaterials on embryonic development.
Several studies have reported the observation of effects of nanomaterials on embryonic 
development.1–2, 19–20, 24, 35–38 However, systematic characterization of the effects of a 
library of well-design nanomaterials on embryonic development has not yet been carried out 
to validate the effectiveness of the embryos as in vivo assays. Many studies did not 
characterize physicochemical properties of individual NPs in vivo in situ in real time. 
Notably, physicochemical properties (e.g., sizes, shapes and surface properties) of individual 
NPs are not identical and they can alter as they are incubated with living organisms. Thus, it 
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is crucial for ones to characterize sizes and doses of individual NPs in vivo in situ in real 
time, in order to quantitatively study dose and size dependent nanotoxicity.
In our previous studies, we exposed the cleavage-stage embryos to the Ag NPs chronically 
for 120 h and found that they died or developed to deformed zebrafish in a dose, size, 
surface-charge, and chemical dependent manners.1–2, 19–20, 24, 35 However, none of these 
previous studies permit us to investigate stage-specific abnormalities. In this study, we select 
vital and representative developmental-stage (cleavage, early-gastrulation, early-
segmentation, late-segmentation, and hatching stages) embryos, acutely expose them to the 
purified and stable Ag NPs (13.1 ± 2.5 nm) for only 2 h, and then characterize their 
development in egg water over 120 h. This study aims to determine whether Ag NPs can 
incite stage-dependent abnormalities, understand their stage-dependent toxicity, and identify 
important embryonic developmental stages for further analysis. This study also aims to 
identify the most sensitive embryonic developmental stages, and use them as ultrasensitive 
in vivo assays to screen biocompatibility and toxicity of nanomaterials.
Experimental Section
Synthesis and Characterization of Ag NPs (13.1 ± 2.5 nm)
The Ag NPs were synthesized and characterized as we described previously.2–3, 22, 39 
Briefly, silver perchlorate solution (0.1 mM in nanopure deionized (DI) water) was mixed 
with a freshly prepared ice-cold solution of sodium citrate (3 mM) and sodium borohydride 
(10 mM) under stirring overnight to produce Ag NPs. The NP solutions were filtered 
through a 0.22 μm filter, and washed three times with nanopure deionized (DI) water using 
centrifugation to remove the chemicals involved in NP synthesis. The NPs were resuspended 
in DI water before incubating with embryos. The washed Ag NPs were very stable (non-
aggregated) in DI water for months and remained stable in egg water (1.0 mM NaCl in DI 
water) throughout the entire embryonic development (120 h). The supernatants of NP 
solutions after the third washing were collected for control experiments to study the effect of 
trace chemicals involved in NP synthesis on the embryonic development.
The concentrations, optical properties, and sizes of NPs were characterized using UV-vis 
spectroscopy, dark-field optical microscopy and spectroscopy (DFOMS), dynamic light 
scattering (DLS), and high-resolution transmission electron microscopy (HR-TEM) (FEI 
Tecnai G2 F30 FEG).2, 20, 22–24 Our DFOMS has been well described previously for real-
time imaging and spectroscopic characterization of single NPs in solutions, single live cells 
and single embryos, and for single molecule detection.1–3, 8–9, 13–14, 18–23, 35, 40–42 In this 
study, EMCCD camera coupled with a SpectraPro-150 (Roper Scientific) was used to 
characterize LSPR spectra of single NPs. A high-resolution CCD camera (Micromax, 5 
MHz, interline) was used to study the transport and diffusion of single NPs in solution and 
in embryos. All chemicals were purchased from Sigma and used without further purification 
or treatment. We used the nanopure DI water (18 MΩ, Barnstead) to prepare solutions and 
rinse glassware.
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Breeding and Monitoring of Zebrafish Embryos
Wild type adult zebrafish (Aquatic Ecosystems) were maintained, bred, and collected, as 
described previously.1–3, 19–20, 24, 35, 43 Each given developmental stage embryos were 
collected, transferred into a petri dish containing egg water, and washed three times with egg 
water to remove the surrounding debris. The washed embryos were then used for real-time 
imaging of the stage-dependent diffusion and transport of single Ag NPs into/in embryos 
and for study of their dose and stage dependent effects on embryonic development. All 
experiments involving embryos and zebrafish were conducted in compliance with IACUC 
guidelines.
In Vivo Real-time Imaging of Diffusion and Transport of Single Ag NPs into/in Embryos
We incubated the given-stage embryos with 0.2 nM Ag NPs in a microchamber and 
immediately imaged the transport and diffusion of single NPs into/in embryos using our 
DFOMS. We also incubated the given-stage embryos with 0.2 nM Ag NPs for 2 h, 
thoroughly rinsed them with egg water to remove external NPs, and incubated them with 
egg water to study the transport and diffusion of single NPs in embryos using DFOMS. We 
acquired LSPR spectra and colors of single Ag NPs using DFOMS, and used their 
distinctive plasmonic colors to identify and distinguish them from embryonic debris and 
zebrafish tissues, which appear white under dark-field illumination.
Study of Dose and Stage-Dependent Toxicity of the Ag NPs
The given-stage embryos were incubated with a dilution series of the Ag NPs (0, 0.02, 0.04, 
0.05, 0.06, 0.07, 0.2, 0.4, 0.5, 0.6, and 0.7 nM) or (0, 0.15, 0.30, 0.37, 0.45, 0.52, 1.34, 2.60, 
3.94, 4.61, and 4.90 mg/L) for 2 h (acute treatment). Molar concentrations of NPs were 
calculated as we described previously.1–3, 19–20, 24, 35 The embryos were then thoroughly 
rinsed with egg water to remove external NPs, and placed in the wells of a 24 well-plate 
containing egg water with 4 embryos per well. As control experiments, the embryos that had 
been incubated with egg water (blank control) or supernatant (in the absence of NPs) for 2 h 
were rinsed and placed in two rows of the same well plates, aiming to determine the 
potential effects of trace chemicals from NP synthesis.
The embryos in the well plates were incubated at 28.5°C, and directly imaged at room 
temperature every 24 h using an inverted microscope (Zeiss Axiovert) equipped with a 
digital color camera, aiming to study the stage-dependent embryonic development. Each 
experiment was carried out at least 3 times and 48 embryos were studied for each given NP 
concentration and each stage of the embryos to gain representative statistics.
Results and Discussion
Synthesis and Characterization of Purified and Stable Ag NPs (13.1 ± 2.5 nm)
We have synthesized and purified spherical Ag NPs using the approaches described in 
Methods.2–3, 13–14, 40 We characterized sizes, shapes and plasmonic optical properties of the 
purified Ag NPs dispersed in egg water (embryonic medium) for 120 h using high resolution 
transmission electron microscopy (HRTEM), and dark-field optical microscopy and 
spectroscopy (DFOMS) (Figure 1). TEM image and histogram of size distribution of single 
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Ag NPs show the spherical NPs with average diameters of 13.1 ± 2.5 nm, ranging from 10 
to 20 nm (Figure 1A and B).
A representative optical image of single Ag NPs shows that the majority of NPs are blue 
with some being green and a few red (Figure 1C). The LSPR spectra of single blue, green 
and red Ag NPs show peak wavelengths (full-width-at-half-maximum), λmax (FWHM), of 
468 nm (38 nm), 554 nm (47 nm), and 659 nm (47 nm), respectively (Figure 1D). Notably, 
the LSPR spectra of single Ag NPs highly depend upon their size, shape, dielectric constant, 
and surrounding environment. The red shift of their LSPR spectra suggests that a very few 
NPs may have high aspect ratios, rough surfaces or larger sizes that have gone undetected by 
TEM. The results demonstrate the powerful detection capabilities of DFOMS to identify and 
characterize very few individual NPs in a mix population of NPs in solution.
We also determine the solubility and stability (non-aggregation) of the Ag NPs suspended in 
egg water (0.7 nM) over 120 h at 28.5 °C by characterizing their number, concentrations and 
sizes over time using DFOMS, UV-vis spectroscopy and dynamic light scattering (DLS) 
(Figure 2), respectively. We characterize the stability of various concentrations of the Ag 
NPs in egg water and determine the highest concentration of Ag NPs (0.7 nM) that are stable 
in egg water and use it in this study. The results show that the number of NPs suspended in 
egg water remains essentially unchanged over 120 h (Figure 2A), indicating that the Ag NPs 
are very stable (non-aggregated) in egg water over time. Furthermore, UV-vis absorption 
spectra of the NPs show that their peak absorbance of 0.49 at 393 nm (FWHM = 64 nm) 
remain unchanged, indicating that NP concentration in egg water remains unchanged 
(Figure 2B). The sizes of Ag NPs in egg water (13.2 ± 3.1 nm) also remain unchanged over 
their 120-h incubation in egg water, as determined by DLS (Figure 2C). Taken together, the 
results (Figure 2) show that the Ag NPs are very stable (non-aggregated) in egg water over 
120 h. If NPs were aggregated, the number of NPs suspended in egg water and its 
concentration would have decreased, and their sizes would have increased over time. That is 
not what we observed. Thus, the Ag NPs are very stable and remain unchanged in egg water 
over 120 h.
It is essential for one to use purified and stable NPs to study their dose, size and stage-
dependent effects on embryonic development. The unpurified Ag NPs contain undetermined 
amounts of a wide range of chemicals (e.g., AgNO3, sodium citrate, etc) involved in NP 
synthesis. These chemicals, instead of the NPs, can potentially cause different effects on 
embryonic development, and lead to inconclusive or irreproducible results. Furthermore, 
unstable Ag NPs in egg water could alter their sizes and concentrations over time, due to 
aggregation, and lead to various sizes and doses of NPs, which would make the study of 
dose and size dependent nanotoxicity unreliable. Thus, we strive to prepare and characterize 
the purified and stable Ag NPs first, and then study their dose, size and stage dependent 
effects on embryonic development.
In this study, we use molar concentrations of the NPs to describe their transport and dose 
dependent effects on embryonic development. Molar concentrations of single Ag NPs (but 
not atoms or ions) are determined by dividing moles of Ag NPs (number of NP/Avogadro 
constant) by total solution volume, as we described previously.1–3, 19–20, 35
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It is worth noting that molar concentration of the NPs is the most appropriate unit to 
characterize and describe dose and stage dependent effects of the NPs on embryonic 
development because molar concentration is proportional to the number and surface 
properties of individual NPs, and it enables the study of dose (number) and surface 
dependent effects of the NPs. Furthermore, unlike conventional chemicals, individual NPs 
are independent entities and have its own NP weights and its own physicochemical 
properties (e.g., sizes, morphologies, surface areas, reactivity, and optical properties). Thus, 
weight of different sizes of the NPs cannot be described by the same atomic weight of Ag, 
and the w/v (weight/volume) of Ag NPs cannot be used to accurately describe NP 
concentration. Notably, the same w/v of different-sized NPs contains different number of the 
NPs, different surface areas and charges. Therefore, the w/v concentration does not represent 
number (doses) of NPs, and cannot accurately reflect dose (number) and surface dependent 
effects of NPs on embryonic development.
Early-Developing Embryos as In Vivo Model Organisms and Assays
Optical images (Figure 3) show normally developing zebrafish embryos at: (A) cleavage 
(0.75–2.25 hours-post-fertilization, hpf), (B) early-gastrula (6 hpf), (C) early-segmentation 
(12 hpf), (D) late-segmentation (21 hpf), and (E) hatching stage (48 hpf). We name them 
(A–E) as stage I–V embryos, respectively. We select the embryos at these five critical 
developmental stages, incubate them with given doses (0–0.7 nM) of the Ag NPs for only 2 
h (acute treatment), thoroughly rinse them with egg water to remove external NPs, and then 
incubate them in egg water at 28.5 °C over 120 h until they fully develop.
These five developmental stages are vital checkpoints of embryonic development. Cleavage-
stage embryos (stage-I: 2–4 hpf) undergo dramatic changes (e.g., rapid cellular division and 
embryonic pattern formation) to lay down the foundation for the development of different 
parts of organs.44–45 Gastrula-stage embryos (stage-II: 6–8 hpf) undergo cell movements 
and migrations to establish the early organ systems.46–47 Early segmentation stage embryos 
(stage-III: 12–14 hpf) begin morphological cell differentiation, morphological movements, 
somitogenesis and notochord formation, which is important for proper development of the 
axial skeleton, the vertebrate spinal column, and the skeletal muscle.46, 48 Late segmentation 
stage embryos (stage IV: 21–23 hpf) undergo development of the circulatory system and the 
formation of heart.46 The hatching-stage embryos (stage V: 48–50 hpf) are finishing up their 
embryonic development. At this stage, all related organs have been formed.43, 46
Notably, massive amount of embryos can be generated rapidly (over night) at very low cost. 
Furthermore, in vivo organisms (embryos) have numerous advantages over in vitro cultured 
cells for study of biocompatibility and toxicity of NPs. For instance, embryos enable one to 
simultaneously investigate the effects of NPs upon a wide variety of cells, and detect all 
related toxicity pathways, including reactive oxygen species formation, engagement of 
apoptotic pathways and disruption of regulatory signaling in the developing embryos. In 
contrast, an in vitro assay typically uses a single type of cultured cells and can miss vital 
cell-specific interactions. Thus, the given-stage embryos can potentially serve as 
ultrasensitive and high-throughput in vivo assays to screen biocompatibility, toxicity and 
therapeutic effects of nanomaterials.
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Real-Time Study of Stage-Dependent Transport of Single Ag NPs into/in Embryos
To study the potential stage-dependent transport and diffusion of single Ag NPs into/in 
embryos, we incubate Ag NPs with the given-stage embryos (Figure 3A–E) and directly 
image their diffusion and transport into and inside the embryos in real time. We focus on 
three critical locations of embryos: chorion layers (CL), chorion space (CS) and interface of 
inner mass embryos (IME) and CS, as marked by squares of (a–c) in Figure 3A–E, aiming to 
determine whether and how single NPs transport into embryos from egg water. Note that the 
monomode (black/white) of the camera with the highest speed is used to track the diffusion 
of single NPs in real time (Figures 4–6). We acquire LSPR spectra and colors of single Ag 
NPs using DFOMS (Figure 1D), and use their distinctive plasmonic colors and spectra to 
identify and distinguish individual NPs from each other, and from embryonic debris and 
tissues, which appear white under dark-field illumination. Real-time sequential optical 
images coupled with distinguished LSPR spectra of single NPs enable us to track the same 
NPs as they diffuse into and through the embryos over time.
Optical images of the CL, the interface between egg water and CS of stage I–V embryos as 
marked by two dash-lines in Figure 4a, show an array of chorionic pore canals (CPCs, white 
dots as squared), and single Ag NPs diffuse through the pores into the embryos as those 
circled. Each pore has diameters of 0.5–0.7 μm and distances between neighboring pores are 
1.5–2.5 μm, which are similar to those we reported previously for cleavage-stage 
embryos.1–3, 20 They show insignificant difference among the various stages of embryos. 
Diffusion trajectories of single Ag NPs (Figure 4b) show that single Ag NPs zigzag through 
the pores and enter the CS. The majority of single NPs pass through the pores and enter the 
CS of embryos, while a very few of NPs are trapped inside the pores from time to time.
To determine the diffusion modes of entry of single Ag NPs into/in the embryos, we use the 
concept of diffusion theories and models (e.g., direct, simple and stationary Brownian 
diffusion).49–51 In this study, we use real-time square-displacement (RTSD) (diffusion 
distance at a given time interval), instead of mean-square-displacement (MSD, average of 
diffusion distances over time), to study diffusion of single NPs in developing embryos in 
vivo in real time. This is because nanoenvironments of developing embryos change rapidly 
over time, and show high viscosity gradients. Therefore, their diffusion coefficients vary 
drastically as single NPs diffuse in developing embryos, and RTSD is more accurate to 
study diffusion modes of single Ag NPs in embryos than MSD.
Plots of RTSD versus time (Figure 4c) show step-wise linearity, which demonstrate that 
single NPs make several attempts to zigzag through the pores and enter the CS. The results 
show stationary Brownian diffusion of single NPs and suggest that random walk and passive 
diffusion of single NPs enable them to pass through the CL and enter the CS. We use the 
slopes of linear portions of the plots to determine the diffusion coefficient (D) of single NPs 
by dividing the slopes by 4 (Note: RTSD = 4Δ3t) using 2D random walk theory, because 
each microscopic image records the 2D diffusion of single NPs. The diffusion coefficients 
of single Ag NPs for the CL of the stage I–V embryos are (2.7 ± 2.4) × 10−10, (2.8 ± 2.6) × 
10−10, (8.8 ± 11) × 10−10, (1.6 ± 1.4) × 10−9, and (8.3 ± 8.5) × 10−10 cm2 s−1, respectively. 
The results show large standard deviations of diffusion coefficients even for the CL of the 
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same stage of embryos, suggesting high heterogeneity of embryonic nano-environments, 
which make the study of stage-dependent diffusion coefficients difficult.
Optical images and diffusion trajectories of single Ag NPs in the CS of stage I–IV embryos 
(Figure 5a and 5b) show that single Ag NPs diffuse in the CS. Plots of RTSD versus time 
(Figure 5c) show linearity and indicate simple random Brownian diffusion of single NPs in 
the CS. As described above, we use the slopes of linear portions of the plots to determine the 
diffusion coefficients of single NPs in the CS of stages I–IV embryos. They are (3.4 ± 1.2) × 
10−9, (1.5 ± 0.4) × 10−9, (4.0 ± 1.9) × 10−10, and (1.0 ± 0.4) × 10−9, respectively.
Optical images and diffusion trajectories of single Ag NPs at the interface of CS and IME of 
stage I–IV embryos (Figure 6a and 6b) show that single Ag NPs diffuse into the IME from 
the CS. Plots of RTSD versus time (Figure 6c) show step-wise linearity. The results indicate 
that simple random Brownian diffusion of single NPs enables them to passively diffuse into 
the IME from the CS. The results also suggest that the NPs are halted from time to time as 
they diffuse through the interface between CS and IME. We use the slopes of linear portions 
of the plots to determine the diffusion coefficient of single NPs at the interface of CS with 
IME for stages I–IV embryos. They are (3.1 ± 0.2) × 10−10, (1.4 ± 1.0) × 10−9, (1.3 ± 1.1) × 
10−9, and (9.4 ± 5.1) × 10−10, respectively. We can not determine diffusion and trajectories 
of the NPs both in CS and in the IME of the stage-V (hatching) embryos due to their 
movement.
Notably, diffusion coefficients of single NPs are inversely proportional to the sizes of NPs 
and viscosities of medium, as described by Stokes-Einstein equation, D = kT/(6πηa), where 
k is Boltzmann constant; T is temperature; a is radii of single NPs; and η is viscosity of 
medium where NPs diffuse in.52 Thus, the diffusion coefficients of the same-sized NPs 
(Figures 4–6) enable us to study the location-dependent viscosities of embryonic 
environments. The results (Figures 4–6) show the highest barrier (viscosity) at the CL, 
followed by the interface of CS and IME, and the lowest one in CS, for single NPs to diffuse 
into/in embryos, as those we reported previously.1–3, 20 Nonetheless, due to the high 
heterogeneity of embryonic nano-environments, we observe insignificant stage-dependent 
diffusion coefficients among various stages of embryos.
Dose- and Stage-Dependent Biocompatibility and Toxicity of Ag NPs
We expose stage I–V embryos with a dilution series of Ag NPs (0–0.7 nM) for 2 h and 
monitor their development in egg water over 120 h. The results show that the NPs induce 
stage and dose-dependent nanotoxicity toward the embryonic development (Figure 7). As 
the NP concentration increases from 0 to 0.7 nM, the percentages of embryos that develop 
normally decrease.
For stage-I embryos (Figure 7A), (56 ± 5)% of the embryos develop normally, (31 ± 10)% 
of them die and (13 ± 4)% of them develop to deformed zebrafish over 120 h, upon their 
acute exposure to 0.02 nM NPs (the lowest dose) for 2 h. The percentages of dead embryos 
and deformed zebrafish increase sharply as the NP concentration increases, and only 48% (< 
50%) of embryos develop normally as the NP concentration increases to 0.04 nM, which is 
around the critical concentration at which 50% of embryos develop normally (Table 1). At 
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0.2 nM NPs, only (3 ± 2)% of the embryos develop normally, (67 ± 14)% of them die and 
(31 ± 7)% develop to deformed zebrafish. At 0.5 nM NPs, none of embryos develop 
normally, (25 ± 14)% of them die and (75 ± 4)% develop to deformed zebrafish. At 0.7 nM 
NPs, the percentages of dead embryos increase to (75 ± 4)%, while the percentages of 
embryos that develop to deformed zebrafish decrease to (25 ± 4)%.
Unlike stage-I embryos, majority of stage-II embryos (75%) develop normally, only 25% of 
them die, and none of embryos develop to deformed zebrafish, upon their acute exposure to 
0.02 nM NPs for 2 h (Figure 7B). The percentages of embryos that develop normally 
decrease much more gradually than stage-I embryos as the NP concentration increases. The 
46% of embryos (< 50%) develop normally as the NP concentration increases to 0.2 nM, 
which is around the critical concentration (Table 1). At 0.7 nM NPs, (29 ± 10)% of the 
embryos still develops normally, while (71 ± 10)% of them die.
For stage-III embryos (Figure 7C), only (41 ± 13)% of embryos develop normally, while (59 
± 13)% of them die and none of them develop to deformed zebrafish over 120 h, upon their 
acute exposure to 0.02 nM NPs for 2 h. The results indicate that the critical concentration of 
NPs to induce nanotoxicity is less than 0.02 nM. The percentages of stage-III embryos that 
develop normally decrease even more drastically, while dead embryos and deformed 
zebrafish increase even more sharply, than those of stage-I embryos, as the NP concentration 
increases. At 0.07 nM NPs, none of the embryos develop normally, (66 ± 5)% of them die 
and (34 ± 5)% of them develop to deformed zebrafish. At 0.7 nM, the percentages of dead 
embryos increase to 100%, while the percentages of embryos that develop to deformed 
zebrafish decrease to zero.
For stage-IV embryos (Figure 7D), only (19 ± 9)% of the embryos develop normally, while 
(38 ± 3)% of them die and (44 ± 4)% of them develop to deformed zebrafish, upon their 
acute exposure to 0.02 nM NPs for 2 h. Thus, the critical concentration of the NPs that cause 
only 50% of the embryos develop normally is far below 0.02 nM. The percentages of the 
embryos that develop normally then decrease gradually, and dead embryos and deformed 
zebrafish increase gradually, as the NP concentration increases. At 0.7 nM NPs, none of the 
embryos develop normally, (63 ± 18)% of them die and (38 ± 18)% of them develop to 
deformed zebrafish.
For stage-V embryos (Figure 7E), majority of the embryos (94%) develop normally, and 
only 6% of them die, upon their acute exposure to 0.02 nM NPs for 2 h. The percentages of 
embryos that develop normally decrease even much more gradually than those of stage-II 
embryos as the NP concentration increases from 0.02 to 0.2 nM. At 0.7 nM NPs, (44 ± 7)% 
of embryos (< 50%) still develop normally, and (56 ± 7)% of embryos die. Thus, the critical 
concentration of NPs that create nearly half of normal zebrafish is ~0.7 nM (Table 1). 
Similar to stage-II embryos, none of stage-V embryos develop to deformed zebrafish upon 
their acute exposure to the NPs (0–0.7 nM) for 2 h.
Two control experiments are carried out simultaneously by incubating stage I–V embryos 
with egg water alone (blank control) and supernatant collected from the last washing of the 
NPs for 2 h, and monitoring the embryonic development in egg water over 120 h. Similar to 
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those of blank control, (80–100)% of embryos develop normally, and none of embryos 
develop to deformed zebrafish, which are independent upon the concentrations (doses) of 
supernatant (Figure 7F). The control experiments with the supernatants allow us to eliminate 
potential toxic effects of trace chemicals (e.g., Ag+) resulted from the Ag NP synthesis or 
their potential degradation over time, and to validate that the observed toxic effects of the 
NPs on embryonic development are attributed to the NPs, but not other chemicals.
Taken together, these interesting findings show unambiguous stage- and dose- dependent 
toxic effect of Ag NPs upon embryonic development. Unlike what we observed in the large 
Ag NPs (97 ± 13 nm),53 the results show that stage-IV embryos are most sensitive to the 
toxic effects of the NPs with the lowest critical concentration of NPs (≪ 0.02 nM), which is 
followed closely by stage-III (< 0.02 nM), stage-I (0.04 nM), and stage-II embryos (0.2 nM), 
while stage-V embryos are most resistant to the NPs with a critical concentration of 0.7 nM 
(Table I).
Notably, for stage-IV and III embryos, the first cells differentiate morphologically, and the 
first body movements appear. A wide variety of morphogenetic movements occur, the 
somite develops and rudiments of the primary organs (e.g., heart) become visible.54 Thus, 
the effects of the NPs on embryonic development are likely to be more direct, perhaps 
disrupting cell differentiation, which leads to the highest level of toxicity. Interestingly, the 
exposure of the stage-I embryos to the NPs creates lasting and severe effects on the 
embryonic development, which may be attributed to the disruption of the earliest 
determinative events. In contrast, stage-V (hatching) embryos have nearly completed their 
development of most of the key organs required for their survival.54 Thus, they are much 
more resistant to the effects of NPs, and their exposure to the Ag NPs generates least 
impacts on their development. Notably, the toxic effects of NPs on embryonic development 
increase with their concentration, suggesting an unclear threshold. These results indicate that 
Ag NPs may not be simple poisons and suggest that they may have specific targets during 
embryonic development. Our observations of stage-specific morphological defects (Figures 
8 and 9) further support such hypothesis.
Stage-Specific Embryonic Phenotypes
After stage-I embryos are exposed to the Ag NPs for 2 h, some of the embryos develop to 
deformed zebrafish with all five types of abnormalities, including (a) abnormal finfold, (b) 
tail/spinal cord flexure, (c) cardiac malformation, (d) yolk sac edema, and (e–f) acephaly 
(no-head) (Figure 8A). Acephaly (a rarely observed severe phenotype) is only observed for 
stage-I embryos treated with the higher NP concentrations (0.06 and 0.6 nM) (Figure 8A: e 
and f). The deformed zebrafish has a small amount of tissue where the head would normally 
develop. The tissue is not a fully formed head but rather an irregular formed mass of tissue.
Interestingly, after stages III and IV embryos are treated with the Ag NPs for 2 h, we 
observe only four types of abnormalities (a–d) (Figure 8B and C), without acephaly. 
Notably, none of stages II and V embryos develop to any type of deformed zebrafish, upon 
their acute exposure to the NPs (0–0.7 nM). This is most likely due to the specific time of 
development because the cells in cleavage-stage embryos are in the process of cleaving to 
lay out the map to form the head and caudal regions of the developing organism. If the cells 
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do not divide properly, then one region of the body axis will not be fully formed. Previous 
studies have showed that inhibiting p38 kinase activity led to undivided blastomeres on one 
side of the embryonic mass.55
Finfold abnormalities with the affected median finfold region (Figure 8a) are one type of 
shared abnormalities of deformed zebrafish developed from stages I, III, and IV embryos 
treated with the NPs. In normally developed zebrafish (Figure 8D), the median finfold is a 
clear, thin membrane around the entire trunk region containing un-segmented fin rays. In the 
deformed zebrafish, the tissue structures of the finfold are disorganized, and in the severest 
cases, the shapes of the finfold and fin rays are altered (Table S1 in supporting information 
and Figure 8a).
Abnormal tail/spinal cord flexures are the other shared defects of deformed zebrafish 
developed from stages I, III, and IV embryos treated with the NPs (Figure 8b). This defect is 
often accompanied by finfold abnormalities. In normally developed zebrafish (Figure 8D), 
the notochord and spinal cord develop straight to the posterior-most tip of the tail. However, 
in the deformed zebrafish, the tail regions are flexed to some extent. The severity of tail 
flexures increases with NP concentration. In the severest cases, the flexure is extreme and 
the overall length of the tail is reduced (Table S1 in supporting information and Figure 8b).
Cardiac malformation and edema are another type of the shared abnormalities of the 
deformed zebrafish developed from stages I, III, and IV embryos treated with the NPs 
(Figure 8c). In contrast to normally developed zebrafish (Figure 8D), the pericardial sac 
region of deformed zebrafish developed from the treated embryos is swollen and enlarged 
(Figure 8c). In the severest cases, the pericardial sac is extremely large and the size of 
cardiac ventricle is reduced (Table S1 in supporting information and Figure 8c).
Yolk sac edema is another type of the shared abnormalities of deformed zebrafish developed 
from stages I, III and IV embryos treated with the NPs (Figure 8d). In normally developed 
zebrafish (Figure 8D), the yolk sac region is a bulbous area containing yolk that provides 
nutrients to the developing embryos and it shrinks during the later developmental stages. In 
contrast, the deformed zebrafish show swollen and enlarged yolk sac region (Figure 8d). In 
some cases, they also display edema of the pericardial sac region (Table S1 in supporting 
information and Figure 8d).
Finfold abnormalities account for the majority of defects of deformed zebrafish developed 
from the stages I and III embryos treated with the NPs with accumulation percentages of 
35% and 36% (sum of percentages of the finfold abnormalities observed in all NPs 
concentrations), respectively (Figure 9A, B). The percentages of finfold abnormalities 
increase as the NP concentration increases. For stage-I embryos, cardiac malformation/
edema (23%), the tail flexure (20%), and yolk sac edema (20%) are the secondary defects 
with nearly equal amount, and acephaly (2%) is the rarely observed defect. For stage-III 
embryos, the cardiac malformation (25.5%) and yolk sac edema (25.5%) is the secondary 
defects with the equal percentages, and the tail flexure (13%) is the tertiary abnormality. In 
contrast, cardiac malformation/edema is the primary abnormality of deformed zebrafish 
developed from the stage IV embryos treated with the NPs with accumulation percentages of 
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44% (Figure 9C). The yolk sac edema (26%) is the secondary defect. Finfold abnormality 
(18%) is the tertiary, and the tail flexure (12%) is the quaternary.
For stage-I embryos, organ structures (e.g., finfold, tail, cardiac, and head) are not yet 
present; presumably the earliest determinative events that will generate these structures are 
ongoing. Thus, the defects we observed 4 days later (at 120 hpf) must have been 
downstream effects of disruptions occurring at the level of determination, and/or the effects 
of retention of NPs following earlier exposures. Specific determinative processes disrupted 
by the NPs may include their effects on gene transcription, cell signaling and cell-cell 
communication. Treatment of stage-I embryos uniquely produces acephalic abnormality 
(Figure 8e and f). The occurrence of this defect is notable given that the formation of head 
structures will not occur until many hours following the exposure, suggesting that Ag NPs 
target regulatory molecules during this determinative stage of development. The acephalic 
phenotype bears a resemblance to that seen in dickkopf (ddk) zebrafish mutants.56 This 
cysteine-rich protein is thought to be a key inducer required for head formation in zebrafish.
For stage-III embryos, the differentiation of organ structures and formation of somites and 
notochord are underway. These structures are important for proper development of the axial 
skeleton, the vertebrate spinal column, and the skeletal muscle.48 Thus, the effects of the 
NPs upon the developmental abnormalities are likely to be more direct, perhaps disrupting 
the synthesis of key proteins (e. g., actin) and/or the formation of cytoskeletal structures 
required to support finfold and somite formation and their proper organization.57
For stage-IV embryos, the formation of last somites, circulatory system and heart 
occurs.46, 54 The heart is preparing for its first contraction.46 Like stage-III embryos, the 
effects of the NPs upon the developmental abnormalities are likely to be more direct, 
perhaps disrupting the formation of circulatory system and heart, which leads to the primary 
cardiac malformation/edema with extremely large pericardial sac and small cardiac 
ventricles.
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Refer to Web version on PubMed Central for supplementary material.
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In summary, we have synthesized, purified and characterized nearly spherical shaped Ag 
NPs with average diameters of (13.1 ± 2.5) nm. We found that the Ag NPs passively 
diffuse through the CL into various developmental stages of embryos via choronic pores, 
in CS and into IME, showing insignificant stage-dependent diffusion modes and 
diffusion coefficients due to the high heterogeneity of embryonic nano-environments. 
The CL creates the highest barrier (viscosity) for single Ag NPs to diffuse across, while 
CS offers the lowest viscosity for the NPs to diffuse around. Notably, the Ag NPs incite 
distinctive stage-dependent toxicity and create stage-specific phenotypes upon their 
exposure to the NPs (0.02–0.7 nM) for only 2 h, instead of 120 h. The results show 
unambiguous stage- and dose-dependent toxic effect of Ag NPs upon embryonic 
development. Unlike what we observed in the large Ag NPs (97 ± 13 nm),53 late-
segmentation stage embryos are most sensitive to the toxic effects of the NPs with the 
lowest critical concentration of NPs (≪ 0.02 nM), which is followed by early-
segmentation stage (0.02 nM), cleavage-stage (0.04 nM), and gastrula-stage embryos (0.2 
nM), while hatching embryos are most resistant to the NPs (0.7 nM). Cleavage-stage 
embryos develop to five types of abnormalities, including rarely observed acephaly (no-
head), while early and late-segmentation stage embryos develop to only four types of 
abnormalities without acephaly. None of gastrula and hatching embryos develops 
abnormally. Interestingly, the observed defects of treated cleavage-stage embryos suggest 
that NPs create downstream effects of disruptions of early determinative events. The late-
segmentation stage embryos develop to deformed zebrafish with primary cardiac 
malformation/edema, suggesting that the NPs may create direct effects upon embryonic 
development. Notably, the toxic effects of NPs on embryonic development increase with 
their concentration, showing an unclear threshold, and suggesting that Ag NPs can create 
specific targets during embryonic development. Molecular experiments are in progress to 
identify possible regulatory targets for Ag NPs, and their related mechanisms.
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Figure 1. Characterization of sizes, shapes and plasmonic optical properties of single Ag NPs 
dispersed in egg water at 28.5 °C for 120 h
(A) HRTEM images show the spherical shaped Ag NPs.
(B) Histogram of size distribution of single Ag NPs determined by HRTEM indicates their 
average sizes of 13.1 ± 2.5 nm.
(C) Dark-field optical images of single Ag NPs in egg water show that the majority of NPs 
are blue with some being green and red.
(D) Representative LSPR spectra of single Ag NPs in (C) show peak wavelengths (full-
width-at-half-maximum), λmax (FWHM): (a) 468 (38), (b) 554 (47), and (c) 659 (47) nm, for 
the plasmonic blue, green and red NPs, respectively. The scale bars are 10 nm in (A) and 2 
μm in (C). The scale bar in (C) shows the distances among NPs, but not their sizes due to 
optical diffraction limit. Concentration of Ag NPs is 0.7 nM.
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Figure 2. Study of stability (non-aggregation) of Ag NPs dispersed in egg water at 28.5 °C for 120 
h
(A) The average number of NPs per image at 0, 12, 24, 48, 72, 96, and 120 h is (65 ± 0), (66 
± 2), (67 ± 3), (67 ± 4), (70 ± 5), (67 ± 3), and (67 ± 4), respectively, which remains 
essentially unchanged over 120 h. The 20 images similar to those in Figure 1C are acquired 
at each given time using DFOMS.
(B) UV-Vis absorption spectra of the NPs dispersed in egg water at 28.5 °C for (a) 0 and (b) 
120 h show that the background-subtracted peak absorbance of 0.49 at 393 nm (FWHM = 
64 nm) remains unchanged over their 120-h incubation with egg water.
(C) Histograms of size distributions of the NPs dispersed in egg water and measured by 
DLS show their average diameters of (13.2 ± 3.1) nm at: (a) 0 and (b) 120 h, which 
indicates that the sizes of NPs remain unchanged and the NPs are stable (non-aggregated) in 
egg water over their 120-h incubation.
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Figure 3. 
Optical images of specific developmental stages of zebrafish embryos: (A) cleavage (2 hour-
post-fertilization, hpf), (B) early-gastrula (6 hpf), (C) early-segmentation (12 hpf), (D) late-
segmentation (21 hpf), and (E) hatching stage (48 hpf), which are incubated with given 
doses of Ag NPs for 2 h (acute treatment). We name them (A–E) as stage I–V embryos, 
respectively. The representative areas of (a) chorion layer (CL), (b) chorion space (CS) and 
(c) interface of inner mass of the embryo (IME) and CS are highlighted by dash-lined 
squares.
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Figure 4. 
Real-time imaging of transport and diffusion modes of single Ag NPs in chorion layers (CL) 
of stage I–V embryos. (a) Optical images show that single Ag NPs (as circled) diffuse from 
outside chorion (OC) through the pores (an array of white dots) of the CL (highlighted by 
two dashed lines) into the CS. Each pore has diameters of 0.5–0.7 μm and distances between 
neighboring pores are 1.5–2.5 μm. (b) Diffusion trajectories and (c) plots of real-time square 
displacement (RTSD) of single NPs versus diffusion time show stationary random Brownian 
motion of the NPs in the CL of stage I–V embryos with diffusion coefficients of: (A) (2.7 ± 
2.4) × 10−10, (B) (2.8 ± 2.6) × 10−10, (C) (8.8 ± 11) × 10−10, (D) (1.6 ± 1.4) × 10−9, and (E) 
(8.3 ± 8.5) × 10−10 cm2 s−1, respectively. Scale bars are 10 μm in (a), and each pixel is 0.067 
μm in (b).
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Figure 5. 
Real-time imaging of transport and diffusion modes of single Ag NPs in chorion space (CS) 
of the stage I–IV embryos. (a) Optical images show that single Ag NPs (as circled) diffuse 
in CS. The CL and the interface of IME and CS are highlighted by dashed lines. (b) 
Diffusion trajectories and (c) plots of RTSD of single NPs versus diffusion time show 
simple random Brownian motion of the NPs in the CS of stage I–IV embryos with diffusion 
coefficients of: (A) (3.4 ± 1.2) × 10−9, (B) (1.5 ± 0.4) × 10−9, (C) (4.0 ± 1.9) × 10−10, and 
(D) (1.0 ± 0.4) × 10−9 cm2 s−1, respectively. Scale bars are 10 μm in (a), and each pixel is 
0.067 μm in (b).
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Figure 6. 
Real-time imaging of transport and diffusion modes of single Ag NPs from the CS into the 
inner mass of the embryo (IME) of stage I–IV embryos. (a) Optical images show that single 
Ag NPs (as circled) diffuse from CS into IME. The interface of CS and IME are highlighted 
by dashed lines. (b) Diffusion trajectories and (c) plots of RTSD of single NPs versus 
diffusion time show simple and constrained Brownian motion of the NPs at the interface of 
IME and CS of stage I–IV embryos, and their diffusion coefficients of: (A) (3.1 ± 0.2) × 
10−10, (B) (1.4 ± 0.9) × 10−9, (C) (1.3 ± 1.1) × 10−9, and (D) (9.4 ± 5.1) × 10−10 cm2 s−1, 
respectively. Scale bars are 10 μm in (a), and each pixel is 0.067 μm in (b).
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Figure 7. 
Study of dose and stage-dependent toxic effects of Ag NPs on embryonic developments. 
Histograms show that the percentages of given-stage embryos (A–E: stages I–V) that have 
been incubated with given concentrations of Ag NPs or (F) supernatant for 2 h, develop to 
normal and deformed zebrafish or die in egg water over 120 hpf. Deformed zebrafish are not 
observed for (B) stage-II and (E) stage-V embryos treated with the NPs, or any stages of 
embryos treated with the supernatants. The 48 embryos are used for each NP concentration 
and each given stage embryos, and error bars represent standard deviations of 4 replicated 
experiments. Each experiment includes 4 replicates with 4 embryos for each replicate 
measurement.
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Figure 8. 
Optical images of (A–C) deformed and (D) normally developed zebrafish. (A–C) Deformed 
zebrafish are observed as (A) stage-I, (B) stage-III, and (C) stage-IV embryos have been 
incubated with the Ag NPs for 2 h (acute treatment), and develop in egg water over 120 hpf, 
which show (a) finfold abnormality; (b) tail/spinal cord flexure; (c) cardiac malformation/
edema; (d) yolk sac edema, and (e*) and (f*) acephaly (*the severest and rare deformation 
with no-head, but beating heart). Scale bar is 500 μm for all images
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Figure 9. 
Study of dose and stage-dependent embryonic developmental abnormalities: (A) stage-I, (B) 
stage-III, and (C) stage-IV embryos. Histograms of distribution of percentages of the given 
stage embryos, which have been incubated with given concentrations of the NPs for 2 h, and 
develop to deformed zebrafish in egg water at 120 hpf with: (a) finfold abnormality; (b) tail/
spinal cord flexure; (c) cardiac malformation/edema; (d) yolk sac edema, and (e and f) 
acephaly for (A) stage-I embryos, and (a–d) for (B) stage-III and (C) stage-IV embryos. For 
each given stage embryos, the percentages of the embryos that develop to each given 
abnormality are calculated by the number of embryos that develop to the given abnormality 
by the total number of embryos that develop to all types of deformed zebrafish.
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